dc.date.accessioned | 2020-03-10T20:32:18Z | |
dc.date.available | 2020-03-10T20:32:18Z | |
dc.date.created | 2019-04-01T13:01:55Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Ejigu Teshay, Yohannes Magnus, Jeanette H. Sundby, Johanne Magnus, Maria Christine . Health outcomes of asymptomatic HIV-infected pregnant women initiating antiretroviral therapy at different baseline CD4 counts in Ethiopia. International Journal of Infectious Diseases. 2019, 82, 89-95 | |
dc.identifier.uri | http://hdl.handle.net/10852/73894 | |
dc.description.abstract | Objective
To compare health outcomes following initiation of antiretroviral therapy (ART) for asymptomatic HIV-infected pregnant women at different CD4 levels.
Methods
We analyzed data from 706 asymptomatic HIV-infected Ethiopian women initiating ART during pregnancy between February 2012 and October 2016. The outcomes evaluated were CD4 gain, CD4 normalization (CD4 count ≥750 cells/mm3) and occurrence of HIV-related clinical events after twelve months of treatment.
Result
On average, CD4 count (cells/mm3) increased from 391 (95% CI: 372–409) at baseline to 523 (95% CI: 495–551) after twelve months of treatment. Rate of CD4 gain was higher among women with baseline CD4 between 350 and 499 compared to CD4 ≥500 (207 versus 6, p < 0.001). But women with baseline CD4 between 350 and 499 could not catch up with women with CD4 ≥500. Women with baseline CD4 ≥500 had significantly higher likelihood of achieving CD4 normalization as compared to those with CD4 between 350 and 499 (AOR = 0.32, 95% CI: 0.13–0.76). No strong evidence of differential risk in the occurrence of HIV-related clinical events.
Conclusion
Starting ART for asymptomatic HIV-infected women with CD4 count ≥500 cells/mm3 was beneficial to preserve or recover immunity after 12 months of treatment in a resource limited setting. | en_US |
dc.language | EN | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.title | Health outcomes of asymptomatic HIV-infected pregnant women initiating antiretroviral therapy at different baseline CD4 counts in Ethiopia | en_US |
dc.type | Journal article | en_US |
dc.creator.author | Ejigu Teshay, Yohannes | |
dc.creator.author | Magnus, Jeanette H. | |
dc.creator.author | Sundby, Johanne | |
dc.creator.author | Magnus, Maria Christine | |
cristin.unitcode | 185,52,14,0 | |
cristin.unitname | Avdeling for samfunnsmedisin og global helse | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.cristin | 1689437 | |
dc.identifier.bibliographiccitation | info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=International Journal of Infectious Diseases&rft.volume=82&rft.spage=89&rft.date=2019 | |
dc.identifier.jtitle | International Journal of Infectious Diseases | |
dc.identifier.volume | 82 | |
dc.identifier.startpage | 89 | |
dc.identifier.endpage | 95 | |
dc.identifier.doi | https://doi.org/10.1016/j.ijid.2019.02.019 | |
dc.identifier.urn | URN:NBN:no-76942 | |
dc.type.document | Tidsskriftartikkel | en_US |
dc.type.peerreviewed | Peer reviewed | |
dc.source.issn | 1201-9712 | |
dc.identifier.fulltext | Fulltext https://www.duo.uio.no/bitstream/handle/10852/73894/2/Ejigu_2019_Hea.pdf | |
dc.type.version | PublishedVersion | |
dc.relation.project | NFR/262700 | |